Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Mettler-Toledo Introduces New Webinar

Published: Friday, October 26, 2012
Last Updated: Friday, October 26, 2012
Bookmark and Share
Webinar explains how pharma manufacturers can optimize fermentation process.

Mettler-Toledo Process Analytics has released a new webinar intended for pharmaceutical producers involved in biofermentation.

The webinar explains how optimal microorganism growth conditions and consequently higher process yield can be achieved through a program of dissolved carbon dioxide measurement and control.

In biopharmaceutical operations, it is important that process reliability is high at all times. Central to this aim is timely measurement of analytical parameters.

Well known key process parameters include pH, dissolved oxygen, and turbidity. Less recognized but of significant importance in fermentation reactors is carbon dioxide.

Dissolved carbon dioxide levels can be indicative of the quality of cellular metabolism.

High levels of CO2 generally equate to high cellular growth; however, if CO2 levels are excessive, they can reach a concentration that is toxic to the microorganisms.

Low CO2 levels lead to a slow growth rate and extended process duration. In-line CO2 measurement systems provide continuous, real-time data on CO2 concentration levels, allowing rapid corrective action when required.

Mettler-Toledo’s on-demand webinar illustrates how dissolved CO2 measurement and control can keep fermentation cultures in their optimal growth range.

This consequently increases process yield and efficiency of the fermentation process.

The webinar also introduces Mettler-Toledo's InPro 5000i dissolved CO2 sensor, which has been designed specifically for the requirements of the pharmaceutical industry. The webinar is available at www.mt.com.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!